Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Jul 2022 for Seres Therapeutics, Inc., €8.9M.
Filing timeline
BuySaleNutritional Health LTP Fund General Partner LLC
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+115.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Nutritional Health LTP Fund General Partner LLC: trading record in brief
All filings by Nutritional Health LTP Fund General Partner LLC on record concern Seres Therapeutics, Inc. The record holds 3 filings, for trades running from 17 May 2021 to 5 July 2022.
On the market, this insider has only ever bought: 2 purchases, €26.8M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 2 purchases and no sales.
The newest entry dates from 7 July 2022: an open-market purchase of €17.9M, in Seres Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nutritional Health LTP Fund General Partner LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,912,748 shares@ US$3.15100.0% of flowCommon StockSEC:0000899243-22-025721:0
Canonical exit: 3 Oct 2022 (T+90)
295,171 shares0Common StockSEC:0000899243-21-020015:0
2 of 2 declarations
